Search - tctmd.com

Displaying 201 - 220 of 244

Sort: Relevancy | Date

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

Philips Response to ResMed Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea and Chronic Heart Failure

June 11, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Conference News EuroPCR 2015

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Yael L. Maxwell

May 20, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Daily News

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

L.A. McKeown

March 10, 2015

News Daily News

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

Todd Neale

December 16, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Daily News

Sapien XT Given Go-Ahead to Make US Debut

Caitlin E. Cox

June 24, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

Advertisement

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Philips Response to ResMed Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea and Chronic Heart Failure

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

Silent A-fib After Acute MI Portends Poor Outcome

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

PARTNER Analyses Highlight Mortality Curves After TAVR

Sapien XT Given Go-Ahead to Make US Debut

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Study Questions Ability of TAVR to Improve Psychological, General Health

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content